Menu

Search

Rodney Tiffen

Rodney Tiffen

Emeritus Professor, Department of Government and International Relations, University of Sydney
Professor Tiffen is one of Australia’s leading scholars of the media. His teaching and research interests are in the mass media, Australian politics, comparative democratic politics, democratisation and Australian relations with Asia.

His most recent book, co-authored with Ross Gittins, is How Australia Compares (Cambridge University Press, 2004).

He is also author of Diplomatic Deceits: Government, Media and East Timor; Scandals: Media, Politics and Corruption in Contemporary Australia; News and Power; The News from Southeast Asia and numerous articles on mass media and Australian politics.

He is editor of Mayer on the Media: Selected Essays on Australian Media, and co-editor of Australia’s Gulf War. He acted as an observer of South Africa’s media during that country’s first democratic election, and has worked with the Australian Broadcasting Corporation (ABC) reviewing Radio Australia. He currently holds an ARC Discovery Grant to analyse changes in the Australian press’s political reporting over the last 50 years.

Rupert Murdoch’s real-life succession drama is underway in a Nevada courtroom. What might happen next?

Sep 19, 2024 01:23 am UTC| Insights & Views Law

A unique court case is getting under way in Nevada this week. At stake is the future of the Murdoch empire. The case, which begins on September 17 local time, is scheduled to run (in secret) for two weeks, and sometime...

As the FBI raids Mar-A-Lago, Donald Trump reaches for unconvincing historical parallels

Aug 10, 2022 01:38 am UTC| Insights & Views Law

These are dark times for our nation, former US President Donald Trump declared when he announced his mansion at Mar-A-Lago had been raided by FBI agents on Monday night Florida time. An assault like this could only take...

Can Fox News survive without Trump in the White House?

Feb 20, 2021 12:34 pm UTC| Insights & Views Business

Sadly, history has largely forgotten the Rector Thomas Beverley. In 1695, he wrote a book predicting the world would end in 1697. In 1698 he wrote another book, complaining the world had ended but no-one had noticed. If he...

From irreverence to irrelevance: the rise and fall of the bad-tempered tabloids

Apr 01, 2019 17:00 pm UTC| Insights & Views Business

Kick this mob out shouted the front page of The Daily Telegraph on the day that Tony Abbott triumphed in the 2013 federal election. Restraint and modesty have never been the hallmarks of tabloid newspapers. Sometimes they...

1 

Economy

Rising Taiwan-China Tensions Trigger Investor Uncertainty Amid Trump Presidency

Foreign investors are increasingly viewing a potential Chinese invasion of Taiwan as a real, if remote, risk under Donald Trumps presidency. While once unthinkable, tensions across the Taiwan Strait have intensified,...

JPMorgan’s Jamie Dimon Warns of Rising U.S. Stagflation Risks

JPMorgan Chase CEO Jamie Dimon has warned that stagflation remains a real possibility for the U.S. economy, citing mounting risks from geopolitical tensions, soaring deficits, and persistent inflationary pressures....

EU Considers Extending Duty-Free U.S. Lobster Deal Amid Trade Tensions

The European Union is considering extending a deal that grants U.S. lobsters duty-free access, aiming to ease trade tensions with Washington and potentially avoid further tariffs. According to the Financial Times, which...

Gold Prices Rise Amid U.S. Debt Fears and Geopolitical Tensions

Gold prices climbed in Asian trading on Thursday, supported by growing safe-haven demand amid ongoing concerns about U.S. debt levels and rising geopolitical risks. Spot gold rose 0.7% to $3,338.04 an ounce, while June...

New Zealand Slashes Spending in 2025 Budget Amid Global Trade Headwinds

New Zealand unveiled its 2025 budget on Thursday, setting the lowest new spending in a decade at NZ$1.3 billion, as the government adopts strict fiscal discipline in response to global economic uncertainty. Finance...

Politics

Judge Slams Trump Administration for Violating Deportation Order

A U.S. federal judge ruled the government violated a court order by attempting to deport six migrants to South Sudan without adequate notice, intensifying tensions between the judiciary and President Donald Trumps...

Gaza Aid Stalls as Israel Allows Limited Trucks, Ceasefire Hinges on Hostage Deal

Israel has allowed over 100 aid trucks carrying flour, baby food, and medical supplies into Gaza this week, but distribution has stalled due to security concerns, according to UN officials. Despite the entry of trucks...

U.S. Shifts Overseas Disaster Response to Refugee Bureau Amid Criticism

The U.S. State Department is assigning overseas disaster response duties to its Bureau of Population, Refugees and Migration (PRM), a move drawing strong criticism from experts who say the office lacks the experience and...

Kim Jong Un Slams Warship Launch Mishap as “Criminal Act”

North Korean leader Kim Jong Un condemned a serious accident during the launch of a new 5,000-ton warship on Wednesday, calling it a criminal act caused by gross negligence, according to state media KCNA. The mishap...

Canada and U.S. Advance Economic Talks at G7 Finance Summit

Canadas Finance Minister François-Philippe Champagne met with U.S. Treasury Secretary Scott Bessent on Wednesday in Banff, Alberta, during the G7 finance ministers summit. The bilateral meeting, held as part of...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Lenovo Q4 Profit Plunges 64% Despite Revenue Beat, AI PC Push Gains Traction

Lenovo, the worlds largest PC maker, reported a sharper-than-expected 64% drop in fourth-quarter profit, primarily due to a non-cash reduction in the value of warrants. Net profit for the quarter ended March 31 fell to $90...

Baidu Shares Dip as Ad Revenue Miss Overshadows Q1 Earnings Beat and AI Growth

Baidu Inc (NASDAQ: BIDU, HK: 9888) shares dropped 3.3% to HK$83.30 in Thursdays Hong Kong session, underperforming the Hang Seng index, which fell 0.6%. The decline came despite Baidu posting better-than-expected...

Citigroup Expands Citi AI Tools to Boost Global Employee Efficiency

Citigroup has launched Citi AI, a powerful suite of artificial intelligence tools aimed at enhancing internal operations across its global workforce. Initially introduced to staff in Hong Kong, the AI tools are now...

Sam Altman Targets 100M AI Devices by 2026 in $6.5B Push with Jony Ive

OpenAI CEO Sam Altman has revealed plans to launch a groundbreaking AI device by the end of 2026, aiming to sell 100 million units. According to the Wall Street Journal, Altman shared the ambitious goal during a recent...

Xpeng Stock Soars on Strong Q1 Results and Bullish Q2 Forecast

Shares of Chinese electric vehicle maker Xpeng Inc (NYSE: XPEV, HK: 9868) surged after the company posted impressive first-quarter earnings and a bullish forecast for Q2, signaling strong momentum in the competitive EV...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.